<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MD</journal-id>
<journal-title>Marine Drugs</journal-title>
<abbrev-journal-title>MD</abbrev-journal-title>
<issn pub-type="epub">1660-3397</issn>
<publisher>
<publisher-name>Molecular Diversity Preservation International</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3390/md9112469</article-id>
<article-id pub-id-type="publisher-id">marinedrugs-09-02469</article-id>
<article-categories>
<subj-group>
<subject>Short Note</subject></subj-group></article-categories>
<title-group>
<article-title>A New Diketopiperazine, Cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline-<italic>R</italic>-isoleucine), from an Australian Specimen of the Sponge <italic>Stelletta</italic> sp. <xref ref-type="fn" rid="fn1-marinedrugs-09-02469">†</xref></article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ovenden</surname><given-names>Simon P. B.</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-02469">1</xref><xref ref-type="aff" rid="af2-marinedrugs-09-02469">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Nielson</surname><given-names>Jonathan L.</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-02469">1</xref><xref ref-type="aff" rid="af3-marinedrugs-09-02469">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>Liptrot</surname><given-names>Catherine H.</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-02469">1</xref><xref ref-type="aff" rid="af4-marinedrugs-09-02469">4</xref></contrib>
<contrib contrib-type="author">
<name><surname>Willis</surname><given-names>Richard H.</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-02469">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>Tapiolas</surname><given-names>Dianne M.</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-02469">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>Wright</surname><given-names>Anthony D.</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-02469">1</xref><xref ref-type="aff" rid="af5-marinedrugs-09-02469">5</xref></contrib>
<contrib contrib-type="author">
<name><surname>Motti</surname><given-names>Cherie A.</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-02469">1</xref><xref ref-type="corresp" rid="c1-marinedrugs-09-02469">*</xref></contrib></contrib-group>
<aff id="af1-marinedrugs-09-02469">
<label>1</label>Australian Institute of Marine Science, PMB no. 3, Townsville MC, Townsville 4810, Australia; E-Mails: <email>simon.ovenden@dsto.defence.gov.au</email> (S.P.B.O.); <email>jonathon.nielson@acdlabs.com</email> (J.L.N.); <email>catherine.liptrot@jcu.edu.au</email> (C.H.L.); <email>r.willis@aims.gov.au</email> (R.H.W.); <email>d.tapiolas@aims.gov.au</email> (D.M.T.); <email>adwright@hawaii.edu</email> (A.D.W.)</aff>
<aff id="af2-marinedrugs-09-02469">
<label>2</label>Defence Science &amp; Technology Organisation, 506 Lorimer St. Fishermans Bend, Victoria 3207, Australia</aff>
<aff id="af3-marinedrugs-09-02469">
<label>3</label>ACD Labs UK, Building A, Trinity Court, Wokingham Road, Bracknell, Berkshire RG42 1PL, UK</aff>
<aff id="af4-marinedrugs-09-02469">
<label>4</label>Advanced Analytical Centre, James Cook University, Townsville, QLD 4811, Australia</aff>
<aff id="af5-marinedrugs-09-02469">
<label>5</label>College of Pharmacy, University of Hawaii, 34 Rainbow Drive, Hilo, HI 96720, USA</aff>
<author-notes>
<corresp id="c1-marinedrugs-09-02469">
<label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>c.motti@aims.gov.au</email>; Tel.: +61-7-4753-4143; Fax: +61-7-4772-5852.</corresp></author-notes>
<pub-date pub-type="collection">
<year>2011</year></pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>11</month>
<year>2011</year></pub-date>
<volume>9</volume>
<issue>11</issue>
<fpage>2469</fpage>
<lpage>2478</lpage>
<history>
<date date-type="received">
<day>29</day>
<month>8</month>
<year>2011</year></date>
<date date-type="rev-recd">
<day>11</day>
<month>11</month>
<year>2011</year></date>
<date date-type="accepted">
<day>16</day>
<month>11</month>
<year>2011</year></date></history>
<permissions>
<copyright-statement>© 2011 by the authors; licensee MDPI, Basel, Switzerland</copyright-statement>
<copyright-year>2011</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p></license></permissions>
<abstract>
<p>While investigating the cytotoxic activity of the methanol extract of an Australian marine sponge <italic>Stelletta</italic> sp. (Demospongiae), a new diketopiperazine, cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline-<italic>R</italic>-isoleucine) (<bold>1</bold>), was isolated together with the known bengamides; A (<bold>2</bold>), F (<bold>3</bold>), N (<bold>4</bold>), Y (<bold>5</bold>), and bengazoles; Z (<bold>6</bold>), C<sub>4</sub> (<bold>7</bold>) and C<sub>6</sub> (<bold>8</bold>). The isolation and structure elucidation of the diketopiperazine (<bold>1</bold>), together with the activity of <bold>1</bold>–<bold>8</bold> against a panel of human and mammalian cell lines are discussed.</p></abstract>
<kwd-group>
<kwd><italic>Stelletta</italic></kwd>
<kwd>diketopiperazine (DKP)</kwd>
<kwd>cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline-<italic>R</italic>-isoleucine)</kwd>
<kwd>bengamide</kwd>
<kwd>bengazole</kwd>
<kwd>anti-cancer activity</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>1. Introduction</title>
<p>Since the first reported isolation of a diketopiperazine (DKP) from the sponge <italic>Dysidea herbacea</italic> [<xref ref-type="bibr" rid="b1-marinedrugs-09-02469">1</xref>], there have been several reports describing the isolation of this class of compound from other marine sponges [<xref ref-type="bibr" rid="b2-marinedrugs-09-02469">2</xref>–<xref ref-type="bibr" rid="b4-marinedrugs-09-02469">4</xref>]. DKPs are also reported from marine microbial sources [<xref ref-type="bibr" rid="b5-marinedrugs-09-02469">5</xref>–<xref ref-type="bibr" rid="b8-marinedrugs-09-02469">8</xref>], including the proteobacteria <italic>Alcaligenes faecalis</italic>, isolated from the sponge <italic>Stelletta tenuis</italic> [<xref ref-type="bibr" rid="b9-marinedrugs-09-02469">9</xref>]. The metabolites reported in these investigations are mostly the products of 4-hydroxy-proline [<xref ref-type="bibr" rid="b2-marinedrugs-09-02469">2</xref>,<xref ref-type="bibr" rid="b5-marinedrugs-09-02469">5</xref>,<xref ref-type="bibr" rid="b6-marinedrugs-09-02469">6</xref>,<xref ref-type="bibr" rid="b8-marinedrugs-09-02469">8</xref>] or proline [<xref ref-type="bibr" rid="b7-marinedrugs-09-02469">7</xref>] reacting with phenylalanine [<xref ref-type="bibr" rid="b2-marinedrugs-09-02469">2</xref>,<xref ref-type="bibr" rid="b5-marinedrugs-09-02469">5</xref>], arginine [<xref ref-type="bibr" rid="b4-marinedrugs-09-02469">4</xref>], leucine [<xref ref-type="bibr" rid="b5-marinedrugs-09-02469">5</xref>–<xref ref-type="bibr" rid="b7-marinedrugs-09-02469">7</xref>], isoleucine [<xref ref-type="bibr" rid="b7-marinedrugs-09-02469">7</xref>], norvaline [<xref ref-type="bibr" rid="b3-marinedrugs-09-02469">3</xref>] or alanine [<xref ref-type="bibr" rid="b8-marinedrugs-09-02469">8</xref>].</p>
<p>Sponges from the genus <italic>Stelletta</italic> are known to produce a number of other bioactive classes of compounds, including but not limited to steroids [<xref ref-type="bibr" rid="b10-marinedrugs-09-02469">10</xref>], alkaloids [<xref ref-type="bibr" rid="b11-marinedrugs-09-02469">11</xref>,<xref ref-type="bibr" rid="b12-marinedrugs-09-02469">12</xref>], isomalabaricane triterpenes [<xref ref-type="bibr" rid="b13-marinedrugs-09-02469">13</xref>], acetylenic acids [<xref ref-type="bibr" rid="b14-marinedrugs-09-02469">14</xref>] and lysophosphatidylcholines [<xref ref-type="bibr" rid="b15-marinedrugs-09-02469">15</xref>]. Initial interest in the methanol (MeOH) extract of the sponge <italic>Stelletta</italic> sp. was motivated by to its potent activity in the NCI 60 cell line screen and a unique COMPARE analysis profile (average GI<sub>50</sub> 0.5 μg/mL) [<xref ref-type="bibr" rid="b16-marinedrugs-09-02469">16</xref>]. This profile was different to that of the standard chemotherapeutic agents paclitaxel, cisplatin, gemcitadine, bryostatin 1, didemnin B, tamoxifen and vinblastine (data provided by NCI). Subsequent bioassay-guided investigations of this extract led to the isolation of a new DKP cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline- <italic>R</italic>-isoleucine) (<bold>1</bold>), the previously reported bengamides; A (<bold>2</bold>) [<xref ref-type="bibr" rid="b17-marinedrugs-09-02469">17</xref>], F (<bold>3</bold>) [<xref ref-type="bibr" rid="b18-marinedrugs-09-02469">18</xref>], N (<bold>4</bold>) [<xref ref-type="bibr" rid="b19-marinedrugs-09-02469">19</xref>], Y (<bold>5</bold>) [<xref ref-type="bibr" rid="b20-marinedrugs-09-02469">20</xref>], and the previously reported bengazoles; Z (<bold>6</bold>) [<xref ref-type="bibr" rid="b20-marinedrugs-09-02469">20</xref>], C<sub>4</sub> (<bold>7</bold>) [<xref ref-type="bibr" rid="b21-marinedrugs-09-02469">21</xref>] and C<sub>6</sub> (<bold>8</bold>) [<xref ref-type="bibr" rid="b21-marinedrugs-09-02469">21</xref>]. Described in this publication is the isolation and structure elucidation of <bold>1</bold>, together with the activity of compounds <bold>1</bold>–<bold>8</bold>.</p></sec>
<sec sec-type="results|discussion">
<title>2. Results and Discussion</title>
<p>The DKP cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline-<italic>R</italic>-isoleucine) <bold>1</bold> was isolated and the molecular formula C<sub>11</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>, corresponding to four double-bond equivalents, was determined by (+)-ESI-FTMS accurate mass measurement. The <sup>13</sup>C NMR data of <bold>1</bold> contained resonances consistent with the presence of two amide carbonyl groups (δ<sub>C</sub> 170.5 (C-7), 165.4 (C-1)) as the only multiple bonds within the molecule, and a hydroxy methine (δ<sub>C</sub> 66.8 (C-4); δ<sub>H</sub> 4.28, 1H, dd, <italic>J =</italic> 4.6, 4.6 Hz) (<xref ref-type="table" rid="t1-marinedrugs-09-02469">Table 1</xref>). These functionalities accounted for all of the oxygen and nitrogen atoms and all of the multiple bonds in <bold>1</bold>, indicating the molecule to be bicyclic. Analysis of the COSY NMR data of <bold>1</bold> showed an extended <sup>1</sup>H–<sup>1</sup>H spin system from H-9 to H<sub>3</sub>-12 via H-10 and H-11, as well as a vicinal COSY NMR correlation from H-10 to H<sub>3</sub>-13. Observed gHMBC NMR correlations from δ<sub>H</sub> 7.97 to the <sup>13</sup>C NMR resonances at δ<sub>C</sub> 59.1 (C-9), δ<sub>C</sub> 56.7 (C-6), δ<sub>C</sub> 34.8 (C-10) and C-1 positioned this hydrogen at N-8. Further gHMBC NMR correlations from δ<sub>H</sub> 4.00 (H-9) to δ<sub>C</sub> 23.9 (C-11) and δ<sub>C</sub> 14.9 (C-13), as well as to C-1 and C-10, clearly positioned H-9 adjacent to the C-1 carbonyl and N-8, giving rise to an isoleucine moiety (<bold>1A</bold>). Additional gHMBC NMR correlations from 8-N<underline>H</underline> and H-9 to C-7 revealed it was attached to N-8. A further contiguous <sup>1</sup>H–<sup>1</sup>H spin system from H-6 to H<sub>2</sub>-3, in addition to gHMBC NMR correlations from the 8-N<underline>H</underline> and H<sub>b</sub>-3 to C-6, and from H<sub>b</sub>-3 to C-1 established the remaining nitrogen (N-2) to be attached to C-1, C-6 and C-3, giving rise to the two rings within <bold>1</bold>. The planar structure of <bold>1</bold> is as shown (<xref ref-type="fig" rid="f2-marinedrugs-09-02469">Scheme 1</xref>).</p>
<p>The configuration at C-4, C-6 and C-9 of <bold>1</bold> was established through analysis of <sup>1</sup>H–<sup>1</sup>H coupling constants, optical rotation measurement, molecular minimisations and comparison with literature compounds [<xref ref-type="bibr" rid="b3-marinedrugs-09-02469">3</xref>,<xref ref-type="bibr" rid="b6-marinedrugs-09-02469">6</xref>,<xref ref-type="bibr" rid="b7-marinedrugs-09-02469">7</xref>]. The magnitude of the coupling constants associated with H-6 (dd, <italic>J</italic> = 11.0, 6.1 Hz) and the observed COSY NMR correlations between H-6 and H<sub>a/b</sub>-5 established it to have a pseudo-axial orientation, similar to that of cyclo[<sc>l</sc>-(4-hydroxyprolinyl)-<sc>l</sc>-leucine)] (H-6, dd, <italic>J</italic> = 11.1, 6.1 Hz) [<xref ref-type="bibr" rid="b6-marinedrugs-09-02469">6</xref>]. An apparent zero coupling between H-4 (<italic>J</italic> = 4.6, 4.6 Hz) and H<sub>b</sub>-3 or H<sub>a</sub>-5 as evident by lack of observed COSY NMR correlations, and observed couplings to H<sub>a</sub>-3 (<italic>J</italic> = 12.5, 4.6 Hz) and H<sub>b</sub>-5 (<italic>J</italic> = 12.9, 11.0, 4.6 Hz), was indicative of H-4 being orientated at approximately 90° to both H<sub>b</sub>-3 and H<sub>a</sub>-5. The observed weak COSY NMR correlation between 8-N<underline>H</underline> and H-9, and the broad singlet for H-9 (similar to that observed in cyclo-[<italic>S</italic>-proline-<italic>S</italic>-isoleucine)] [<xref ref-type="bibr" rid="b3-marinedrugs-09-02469">3</xref>]), revealed H-9 to be axial. Molecular modelling studies showed that the observed coupling constants were in agreement with either <italic>R</italic>,<italic>R</italic> (<xref ref-type="fig" rid="f1-marinedrugs-09-02469">Figure 1</xref>) or <italic>S</italic>,<italic>S</italic> configuration at C-6/C-9 but definitely not <italic>R</italic>,<italic>S</italic> or <italic>S</italic>,<italic>R</italic> (<xref ref-type="supplementary-material" rid="s1-marinedrugs-09-02469">Supplementary Data S6-S13 and Table S1</xref>). Based on optical rotation trends of DKPs from the literature [<xref ref-type="bibr" rid="b3-marinedrugs-09-02469">3</xref>,<xref ref-type="bibr" rid="b7-marinedrugs-09-02469">7</xref>], the overall positive [α]<sup>21</sup><sub>D</sub> = +12° indicated the absolute configuration at C-6 should be <italic>R</italic>, therefore supporting the <italic>R</italic>,<italic>R</italic> configuration. The magnitude of the optical rotation is also in agreement with other C-4 hydroxylated DKPs [<xref ref-type="bibr" rid="b5-marinedrugs-09-02469">5</xref>,<xref ref-type="bibr" rid="b7-marinedrugs-09-02469">7</xref>]. The molecular model shown in <xref ref-type="fig" rid="f1-marinedrugs-09-02469">Figure 1</xref>, with calculated dihedral angles for H<sub>a</sub>-5–C-5–C-6–H-6 (Φ = 41°), H<sub>b</sub>-5–C-5–C-6–H-6 (Φ = 163°), H-4–C-4–C-5–H<sub>a</sub>-5 (Φ = 79°), H-4–C-4–C-5–H<sub>b</sub>-5 (Φ = −42°), H<sub>a</sub>-3–C-3–C-4–H-4 (Φ = 29°), H<sub>b</sub>-3–C-3–C-4–H-4 (Φ = −93°) and 8-N<underline>H</underline>–N-8–C-9–H-9 (Φ = 91°), best explained the observed COSY NMR correlations, <sup>1</sup>H–<sup>1</sup>H coupling constants and the positive sign of [α]<sup>21</sup><sub>D</sub> confirmed the absolute configuration at C-3, C-6 and C-8 to be as shown. It is likely that this DKP was produced by an enzymatically controlled condensation reaction between <sc>d</sc>-isoleucine and 4-<italic>S</italic>-hydroxy-<sc>d</sc>-proline (<xref ref-type="fig" rid="f2-marinedrugs-09-02469">Scheme 1</xref>) [<xref ref-type="bibr" rid="b22-marinedrugs-09-02469">22</xref>].</p>
<p>The cytotoxicity of <bold>1</bold>–<bold>8</bold> was investigated against the human tumour cell lines H460, SF-268, MCF-7, HT-29 and a normal mammalian cell line CHO-K1. The DKP <bold>1</bold> exhibited minimal activity towards MCF-7, H460 and HT-29 cells and no activity towards SF-268 or CHO-K1 cells at the highest dose (<xref ref-type="table" rid="t2-marinedrugs-09-02469">Table 2</xref>). In contrast, the GI<sub>50</sub> values (μM) for bengamides A (<bold>2</bold>), F (<bold>3</bold>), N (<bold>4</bold>), Y(<bold>5</bold>), and bengazoles Z (<bold>6</bold>), C<sub>4</sub> (<bold>7</bold>) and C<sub>6</sub> (<bold>8</bold>) were comparable to those reported in previous studies [<xref ref-type="bibr" rid="b19-marinedrugs-09-02469">19</xref>,<xref ref-type="bibr" rid="b20-marinedrugs-09-02469">20</xref>], and accounted for the activity observed in the original MeOH extract.</p></sec>
<sec>
<title>3. Experimental</title>
<sec sec-type="methods">
<title>3.1. General Experimental Procedures</title>
<p>General experimental details have been described previously [<xref ref-type="bibr" rid="b29-marinedrugs-09-02469">29</xref>].</p></sec>
<sec>
<title>3.2. Animal Material</title>
<p>This specimen of the sponge <italic>Stelletta</italic> sp., (Family Ancorinidae) was collected from the west side of Jamieson Reef, Bonaparte Archipelago, North West Western Australia, at depths ranging from 16 m to 20 m, in August 1991. A voucher specimen (Accession number QMG312281) has been lodged with the Queensland Museum.</p></sec>
<sec>
<title>3.3. Bioassay</title>
<p>Cellular bioassays were undertaken as previously described [<xref ref-type="bibr" rid="b19-marinedrugs-09-02469">19</xref>].</p></sec>
<sec>
<title>3.4. Extraction and Isolation</title>
<p>Freeze dried sponge material (125 g dry weight) was extracted sequentially with dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>), MeOH and H<sub>2</sub>O; activity was confined to the CH<sub>2</sub>Cl<sub>2</sub> and MeOH fractions. The MeOH fraction was subjected to reversed phase C18 flash vacuum chromatography (RP-C18, 40%, 60%, 80%, 100% MeOH in H<sub>2</sub>O, and 100% CH<sub>2</sub>Cl<sub>2</sub>) with activity located in the 40% and 100% MeOH fractions. The 100% MeOH fraction was further separated using RP HPLC (4 mL/min, gradient elution from 60% acetonitrile (CH<sub>3</sub>CN):H<sub>2</sub>O (+0.1% formic acid [HCO<sub>2</sub>H]) to 100% CH<sub>3</sub>CN (+0.1% HCO<sub>2</sub>H) over 10 min, then isocratic 100% CH<sub>3</sub>CN (+0.1% HCO<sub>2</sub>H) for 15 min through a 150 mm × 10 mm 5 μ Phenomenex Luna C18 column), to give thirteen fractions. The first active fraction, fraction 1, was subjected to RP HPLC (4 mL/min, gradient elution from 20% CH<sub>3</sub>CN:H<sub>2</sub>O (+0.1% HCO<sub>2</sub>H) to 100% CH<sub>3</sub>CN (+0.1% HCO<sub>2</sub>H) over 20 min through a 150 × 10 mm 5 μ Phenomenex Luna Phenyl-Hexyl column) to yield bengamide Y (<bold>5</bold>) (0.8 mg, 0.0006%). The additional active fractions 3 and 4 were both partitioned with <italic>n</italic>-hexane and MeOH (1:1) to yield bengamides N (<bold>4</bold>) (1.4 mg, 0.001%) and A (<bold>2</bold>) (3.3 mg 0.003%), respectively.</p>
<p>The 40% MeOH fraction was subjected to further RP-C18 (10%, 20%, 30%, 40%, 50% and 100% MeOH in H<sub>2</sub>O) and the active fractions (30% and 40% MeOH) fractionated on RP HPLC (4 mL/min, gradient elution from 10% CH<sub>3</sub>CN:H<sub>2</sub>O (+0.1% HCO<sub>2</sub>H) to 64% CH<sub>3</sub>CN:H<sub>2</sub>O (+0.1% HCO<sub>2</sub>H) over 12 min, then isocratic 100% CH<sub>3</sub>CN (+0.1% formic acid) for an additional 5 min through a 150 mm × 10 mm 5 μ Phenomenex Luna C18 column) to yield bengamide F (<bold>3</bold>, 2.1 mg, 0.002%), bengazoles Z (<bold>6</bold>, 5.0 mg, 0.004%), C<sub>4</sub> (<bold>7</bold>) (13.8 mg, 0.011%) and C<sub>6</sub> (<bold>8</bold>) (23.6 mg, 0.012%) and the new DKP cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline-<italic>R</italic>-isoleucine) <bold>1</bold> (1.5 mg, 0.001%).</p>
<sec>
<title>3.4.1. Cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline-<italic>R</italic>-isoleucine) (<bold>1</bold>)</title>
<p>Isolated as a colourless oil. [α]<sup>21</sup><sub>D</sub> +12° (<italic>c</italic> 0.025, CHCl<sub>3</sub>); IR (film) <italic>ν</italic><sub>max</sub> 3391, 1649 cm<sup>−1</sup>; UV (PDA, CH<sub>3</sub>CN/H<sub>2</sub>O) λ<sub>max</sub> 220 nm; <sup>1</sup>H (600 MHz, <italic>d</italic><sub>6</sub>-DMSO) and <sup>13</sup>C (150 MHz, <italic>d</italic><sub>6</sub>-DMSO) NMR data see <xref ref-type="table" rid="t1-marinedrugs-09-02469">Table 1</xref>; ESI-FTMS [M + Na]<sup>+</sup> 249.1203 (calcd. for C<sub>11</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>Na 249.1215).</p></sec>
<sec>
<title>3.4.2. Bengamide A (<bold>2</bold>)</title>
<p>Isolated as a colourless oil. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectral data were consistent with published values [<xref ref-type="bibr" rid="b17-marinedrugs-09-02469">17</xref>].</p></sec>
<sec>
<title>3.4.3. Bengamide F (<bold>3</bold>)</title>
<p>Isolated as a colourless oil. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectral data were consistent with published values [<xref ref-type="bibr" rid="b18-marinedrugs-09-02469">18</xref>].</p></sec>
<sec>
<title>3.4.4. Bengamide N (<bold>4</bold>)</title>
<p>Isolated as a colourless oil. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectral data were consistent with published values [<xref ref-type="bibr" rid="b19-marinedrugs-09-02469">19</xref>].</p></sec>
<sec>
<title>3.4.5. Bengamide Y (<bold>5</bold>)</title>
<p>Isolated as a colourless oil. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectral data were consistent with published values [<xref ref-type="bibr" rid="b20-marinedrugs-09-02469">20</xref>].</p></sec>
<sec>
<title>3.4.6. Bengazole Z (<bold>6</bold>)</title>
<p>Isolated as a colourless oil. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectral data were consistent with published values [<xref ref-type="bibr" rid="b20-marinedrugs-09-02469">20</xref>].</p></sec>
<sec>
<title>3.4.7. Bengazole C<sub>4</sub> (<bold>7</bold>)</title>
<p>Isolated as a colourless oil. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectral data were consistent with published values [<xref ref-type="bibr" rid="b21-marinedrugs-09-02469">21</xref>].</p></sec>
<sec>
<title>3.4.8. Bengazole C<sub>6</sub> (<bold>8</bold>)</title>
<p>Isolated as a colourless oil. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectral data were consistent with published values [<xref ref-type="bibr" rid="b21-marinedrugs-09-02469">21</xref>].</p></sec></sec></sec>
<sec>
<title>4. Conclusion</title>
<p>The DKP cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline-<italic>R</italic>-isoleucine) (<bold>1</bold>), together with the known bengamides; A (<bold>2</bold>), F (<bold>3</bold>), N (<bold>4</bold>), Y (<bold>5</bold>), and bengazoles; Z (<bold>6</bold>), C<sub>4</sub> (<bold>7</bold>) and C<sub>6</sub> (<bold>8</bold>), was isolated from the Australian marine sponge <italic>Stelletta</italic> sp. Interestingly, this is the first report of bengamides or bengazoles from the genus <italic>Stelletta</italic>, however, it should be noted that they have previously been reported from species of <italic>Dorypleres splendens</italic> [<xref ref-type="bibr" rid="b24-marinedrugs-09-02469">24</xref>], which has since been reclassified as <italic>Jaspis splendens</italic>, and from <italic>Jaspis</italic> sp. [<xref ref-type="bibr" rid="b24-marinedrugs-09-02469">24</xref>], both of which belong to the Ancorinidae family of sponges. The cyclo-(4-<italic>S</italic>-hydroxy-<italic>R</italic>-proline-<italic>R</italic>-isoleucine) (<bold>1</bold>) was not cytotoxic against the cell lines MCF-7, H460, HT-29, SF-268 or CHO-K1. The DKP class of compounds has recently gained interest in drug discovery [<xref ref-type="bibr" rid="b25-marinedrugs-09-02469">25</xref>] due to their chiral, rigid and functionalised structures. These features enable them to bind to a large variety of receptors with high affinity giving rise to a broad range of biological activities, including cytotoxicity, quorum sensing, antibacterial, antifungal, antiviral, antiprion, antitumor, and immunosuppressive functions, even plant-growth regulators [<xref ref-type="bibr" rid="b7-marinedrugs-09-02469">7</xref>,<xref ref-type="bibr" rid="b26-marinedrugs-09-02469">26</xref>–<xref ref-type="bibr" rid="b28-marinedrugs-09-02469">28</xref>]. Our report adds to the vast knowledge of these potentially therapeutic molecules.</p></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="s1-marinedrugs-09-02469" content-type="local-data">
<media xlink:href="marinedrugs-09-02469-s001.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Collection of this sponge was made possible by the access and benefit sharing arrangements between AIMS and the Australian Commonwealth Government. The authors are grateful to those AIMS staff, both past and present, involved in the collection of the sponge. We thank A. Carroll, Eskitis Institute, Griffith University for facilitating measurement of optical rotations, and B. Bowden, Department of Pharmacy and Molecular Sciences, James Cook University for use of the Departments’ FTIR instrument. We also thank A-M. Babey, School of Veterinary and Biomedical Sciences, James Cook University for initial cytotoxicity screening data and for the SF268 cell line, and C. Hooi, R. Anderson and C. Cullinane, of the Peter MacCallum Cancer Centre, Melbourne, Australia, for the HT-29, H460, MCF-7 and CHO-K1 cell lines.</p></ack>
<fn-group><fn id="fn1-marinedrugs-09-02469">
<label>†</label>
<p>Dedication: We dedicate this paper to the memory of Dr. Peter Murphy (Townsville, Australia), a former AIMS colleague and dear friend, for his passionate contributions to the field of natural products chemistry and marine biodiversity, in particular recognising the need for access and benefit sharing arrangements between scientific organisations and local communities.</p></fn><fn>
<p><italic>Samples Availability</italic>: Available from the authors.</p></fn></fn-group>
<ref-list>
<title>References</title>
<ref id="b1-marinedrugs-09-02469"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kazlauskas</surname><given-names>R.</given-names></name><name><surname>Murphy</surname><given-names>P.T.</given-names></name><name><surname>Wells</surname><given-names>P.J.</given-names></name></person-group><article-title>A diketopiperazine derived from trichloroleucine from the sponge Dysidea herbacea</article-title><source>Tetrahedron Lett</source><year>1978</year><volume>49</volume><fpage>4945</fpage><lpage>4948</lpage></citation></ref>
<ref id="b2-marinedrugs-09-02469"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adamczeski</surname><given-names>M.</given-names></name><name><surname>Quiñoà</surname><given-names>E.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name></person-group><article-title>Novel sponge-derived amino acids. 5. Structures, stereochemistry, and synthesis of several new heterocycles</article-title><source>J. Am. Chem. Soc</source><year>1989</year><volume>111</volume><fpage>647</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1021/ja00184a037</pub-id></citation></ref>
<ref id="b3-marinedrugs-09-02469"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adamczeski</surname><given-names>M.</given-names></name><name><surname>Reed</surname><given-names>A.R.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name></person-group><article-title>New and known diketopiperazines from the Caribbean sponge, Calyx cf. podatypa</article-title><source>J. Nat. Prod</source><year>1995</year><volume>58</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1021/np50116a007</pub-id><pub-id pub-id-type="pmid">7769388</pub-id></citation></ref>
<ref id="b4-marinedrugs-09-02469"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergne</surname><given-names>C.</given-names></name><name><surname>Boury-Esnault</surname><given-names>N.</given-names></name><name><surname>Perez</surname><given-names>T.</given-names></name><name><surname>Martin</surname><given-names>M.T.</given-names></name><name><surname>Adeline</surname><given-names>M.T.</given-names></name><name><surname>Dau</surname><given-names>E.T.H.</given-names></name><name><surname>Al-Mourabit</surname><given-names>A.</given-names></name></person-group><article-title>Verpacamides A–D, a sequence of C11N5 diketopiperazines relating cyclo(Pro-Pro) to cyclo(Pro-Arg), from the marine sponge <italic>Axinella vaceleti</italic>: Possible biogenetic precursors of pyrrole-2-aminoimadazoles</article-title><source>Org. Lett</source><year>2006</year><volume>8</volume><fpage>2421</fpage><lpage>2424</lpage><pub-id pub-id-type="doi">10.1021/ol0608092</pub-id><pub-id pub-id-type="pmid">16706541</pub-id></citation></ref>
<ref id="b5-marinedrugs-09-02469"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shigemori</surname><given-names>H.</given-names></name><name><surname>Tenma</surname><given-names>M.</given-names></name><name><surname>Shimazaki</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>J.</given-names></name></person-group><article-title>Three new metabolites from the marine yeast <italic>Aureobasidium pullulans</italic></article-title><source>J. Nat. Prod</source><year>1998</year><volume>61</volume><fpage>696</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1021/np980011u</pub-id><pub-id pub-id-type="pmid">9599283</pub-id></citation></ref>
<ref id="b6-marinedrugs-09-02469"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cronan</surname><given-names>J.M.</given-names></name><name><surname>Davidson</surname><given-names>T.R.</given-names></name><name><surname>Singleton</surname><given-names>F.L.</given-names></name><name><surname>Colwell</surname><given-names>R.R.</given-names></name><name><surname>Cardellina</surname><given-names>J.H.</given-names></name></person-group><article-title>Plant growth promoters isolated from a marine bacterium associated with <italic>Palythoa</italic> sp</article-title><source>Nat. Prod. Lett</source><year>1998</year><volume>11</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1080/10575639808044959</pub-id></citation></ref>
<ref id="b7-marinedrugs-09-02469"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fdhila</surname><given-names>F.</given-names></name><name><surname>Vazquez</surname><given-names>V.</given-names></name><name><surname>Sanchez</surname><given-names>J.L.</given-names></name><name><surname>Riguera</surname><given-names>R.</given-names></name></person-group><article-title>DD-diketopiperazines: Antibiotics active against <italic>Vibrio anguilarum</italic> isolated from marine bacteria associated with cultures of <italic>Pecten maximus</italic></article-title><source>J. Nat. Prod</source><year>2003</year><volume>66</volume><fpage>1299</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1021/np030233e</pub-id><pub-id pub-id-type="pmid">14575426</pub-id></citation></ref>
<ref id="b8-marinedrugs-09-02469"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitova</surname><given-names>M.</given-names></name><name><surname>Popov</surname><given-names>S.</given-names></name><name><surname>de Rosa</surname><given-names>S.</given-names></name></person-group><article-title>Cyclic peptides from a Ruegeria strain of bacteria associated with the sponge <italic>Suberites domuncula</italic></article-title><source>J. Nat. Prod</source><year>2004</year><volume>67</volume><fpage>1178</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1021/np049900+</pub-id><pub-id pub-id-type="pmid">15270577</pub-id></citation></ref>
<ref id="b9-marinedrugs-09-02469"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Miao</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name></person-group><article-title>l,l-Diketopiperazines from <italic>Alcaligenes faecalis</italic> A72 associated with South China Sea sponge <italic>Stelletta tenuis</italic></article-title><source>Biochem. Syst. Ecol</source><year>2008</year><volume>36</volume><fpage>230</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.bse.2007.08.007</pub-id></citation></ref>
<ref id="b10-marinedrugs-09-02469"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>Y.M.</given-names></name><name><surname>Djerassi</surname><given-names>C.</given-names></name></person-group><article-title>Steroids from sponges</article-title><source>Tetrahedron</source><year>1974</year><volume>30</volume><fpage>4095</fpage><lpage>4103</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)97391-0</pub-id></citation></ref>
<ref id="b11-marinedrugs-09-02469"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>H.</given-names></name><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name></person-group><article-title>Stellettamide A, an antifungal alkaloid from a marine sponge of the genus <italic>Stelletta</italic></article-title><source>Tetrahedron Lett</source><year>1990</year><volume>31</volume><fpage>4163</fpage><lpage>4164</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)97570-1</pub-id></citation></ref>
<ref id="b12-marinedrugs-09-02469"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Asai</surname><given-names>N.</given-names></name><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Honda</surname><given-names>K.</given-names></name><name><surname>Yasumuro</surname><given-names>K.</given-names></name></person-group><article-title>Cyclostelletamines A–F pyridine alkaloids inhibit binding of methyl quinuclidinyl benzilate (QNB) muscarinic acetylcholine receptors from sponge <italic>Stelletta maxima</italic></article-title><source>Tetrahedron Lett</source><year>1994</year><volume>35</volume><fpage>3967</fpage><lpage>3970</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)76715-3</pub-id></citation></ref>
<ref id="b13-marinedrugs-09-02469"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oku</surname><given-names>N.</given-names></name><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Wada</surname><given-names>S.</given-names></name><name><surname>Watabe</surname><given-names>S.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name></person-group><article-title>New isomalabaricane triterpenes from the marine sponge <italic>Stelletta globostellata</italic> that induce morphological changes in rat fibroblasts</article-title><source>J. Nat. Prod</source><year>2000</year><volume>63</volume><fpage>205</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1021/np990333d</pub-id><pub-id pub-id-type="pmid">10691710</pub-id></citation></ref>
<ref id="b14-marinedrugs-09-02469"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Im</surname><given-names>K.S.</given-names></name><name><surname>Sim</surname><given-names>C.J.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name><name><surname>Jung</surname><given-names>J.H.</given-names></name></person-group><article-title>New acetylenic acids from the marine sponge <italic>Stelletta</italic> species</article-title><source>J. Nat. Prod</source><year>2003</year><volume>66</volume><fpage>408</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1021/np020440z</pub-id><pub-id pub-id-type="pmid">12662102</pub-id></citation></ref>
<ref id="b15-marinedrugs-09-02469"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Mansoor</surname><given-names>T.A.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Im</surname><given-names>K.S.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name><name><surname>Jung</surname><given-names>J.H.</given-names></name></person-group><article-title>New lysophosphatidylcholines and monoglycerides from the marine sponge <italic>Stelletta</italic> sp</article-title><source>J. Nat. Prod</source><year>2003</year><volume>66</volume><fpage>725</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1021/np0300075</pub-id><pub-id pub-id-type="pmid">12762820</pub-id></citation></ref>
<ref id="b16-marinedrugs-09-02469"><label>16</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>M.R.</given-names></name></person-group><article-title>The NCI<italic>in Vitro</italic> Anticancer Drug Discovery Screen: Concept, Implementation and Operation, 1985–1995</article-title><source>Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval</source><person-group person-group-type="editor"><name><surname>Teicher</surname><given-names>B.A.</given-names></name></person-group><publisher-name>Humana Press</publisher-name><publisher-loc>Totowa, NJ, USA</publisher-loc><year>1997</year><fpage>23</fpage><lpage>42</lpage></citation></ref>
<ref id="b17-marinedrugs-09-02469"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quiñoà</surname><given-names>E.</given-names></name><name><surname>Adamczeski</surname><given-names>M.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name><name><surname>Bakus</surname><given-names>G.J.</given-names></name></person-group><article-title>Bengamides; heterocyclic anthelminthics from a jaspidae marine sponge</article-title><source>J. Org. Chem</source><year>1986</year><volume>51</volume><fpage>4494</fpage><lpage>4497</lpage><pub-id pub-id-type="doi">10.1021/jo00373a036</pub-id></citation></ref>
<ref id="b18-marinedrugs-09-02469"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adamczeski</surname><given-names>M.</given-names></name><name><surname>Quiñoà</surname><given-names>E.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name></person-group><article-title>Novel sponge derived amino acids. 11. The entire absolute stereochemistry of the bengamides</article-title><source>J. Org. Chem</source><year>1990</year><volume>55</volume><fpage>240</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1021/jo00288a039</pub-id></citation></ref>
<ref id="b19-marinedrugs-09-02469"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thale</surname><given-names>Z.</given-names></name><name><surname>Kinder</surname><given-names>F.R.</given-names></name><name><surname>Bair</surname><given-names>K.W.</given-names></name><name><surname>Bontempo</surname><given-names>J.</given-names></name><name><surname>Czuchta</surname><given-names>A.M.</given-names></name><name><surname>Versace</surname><given-names>R.W.</given-names></name><name><surname>Phillips</surname><given-names>P.E.</given-names></name><name><surname>Sanders</surname><given-names>M.L.</given-names></name><name><surname>Wattanasin</surname><given-names>S.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name></person-group><article-title>Bengamides revisited: New structures and antitumor studies</article-title><source>J. Org. Chem</source><year>2001</year><volume>66</volume><fpage>1733</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1021/jo001380+</pub-id><pub-id pub-id-type="pmid">11262120</pub-id></citation></ref>
<ref id="b20-marinedrugs-09-02469"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groweiss</surname><given-names>A.</given-names></name><name><surname>Newcomer</surname><given-names>J.J.</given-names></name><name><surname>O’Keefe</surname><given-names>B.R.</given-names></name><name><surname>Blackman</surname><given-names>A.</given-names></name><name><surname>Boyd</surname><given-names>M.R.</given-names></name></person-group><article-title>Cytotoxic metabolites from an Australian collection of the sponge <italic>Jaspis</italic> species</article-title><source>J. Nat. Prod</source><year>1999</year><volume>62</volume><fpage>1691</fpage><lpage>1693</lpage><pub-id pub-id-type="doi">10.1021/np9902688</pub-id></citation></ref>
<ref id="b21-marinedrugs-09-02469"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>J.</given-names></name><name><surname>Nieto</surname><given-names>R.M.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name></person-group><article-title>Novel sponge-derived amino acids. 14. New structures and bioactivity patterns of bengazole alkaloids from a choristid marine sponge</article-title><source>J. Nat. Prod</source><year>1993</year><volume>56</volume><fpage>2034</fpage><lpage>2040</lpage><pub-id pub-id-type="doi">10.1021/np50102a002</pub-id><pub-id pub-id-type="pmid">8133293</pub-id></citation></ref>
<ref id="b22-marinedrugs-09-02469"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balibar</surname><given-names>C.J.</given-names></name><name><surname>Walsh</surname><given-names>C.T.</given-names></name></person-group><article-title>GliP, a multimodular nonribosomal peptide synthetase in <italic>Aspergillus fumigatus</italic>, makes the diketopiperazine scaffold of gliotoxin</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>15029</fpage><lpage>15038</lpage><pub-id pub-id-type="doi">10.1021/bi061845b</pub-id><pub-id pub-id-type="pmid">17154540</pub-id></citation></ref>
<ref id="b23-marinedrugs-09-02469"><label>23</label><citation citation-type="book"><source>ChemBio3D Ultra, version 11.0.1</source><publisher-name>CambridgeSoft</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2008</year></citation></ref>
<ref id="b24-marinedrugs-09-02469"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Hogan</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>J.-P.</given-names></name><name><surname>Tan</surname><given-names>R.</given-names></name><name><surname>Nogawa</surname><given-names>T.</given-names></name><name><surname>Cichacz</surname><given-names>Z.</given-names></name><name><surname>Pettit</surname><given-names>R.K.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Ye</surname><given-names>Q.-H.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name><etal/></person-group><article-title>Antineoplastic Agents. 536. New Sources of Naturally Occurring Cancer Cell Growth Inhibitors from Marine Organisms, Terrestrial Plants, and Microorganisms</article-title><source>J. Nat. Prod</source><year>2008</year><volume>71</volume><fpage>438</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1021/np700738k</pub-id><pub-id pub-id-type="pmid">18327911</pub-id></citation></ref>
<ref id="b25-marinedrugs-09-02469"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnefonda</surname><given-names>L.</given-names></name><name><surname>Araib</surname><given-names>T.</given-names></name><name><surname>Sakaguchib</surname><given-names>Y.</given-names></name><name><surname>Suzukib</surname><given-names>T.</given-names></name><name><surname>Ishitania</surname><given-names>R.</given-names></name><name><surname>Nurekia</surname><given-names>O.</given-names></name></person-group><article-title>Structural basis for nonribosomal peptide synthesis by an aminoacyl-tRNA synthetase paralog</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>3912</fpage><lpage>3917</lpage><pub-id pub-id-type="doi">10.1073/pnas.1019480108</pub-id><pub-id pub-id-type="pmid">21325056</pub-id></citation></ref>
<ref id="b26-marinedrugs-09-02469"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>M.B.</given-names></name><name><surname>Carvalho</surname><given-names>I.</given-names></name></person-group><article-title>Diketopiperazines: Biological activity and synthesis</article-title><source>Tetrahedron</source><year>2007</year><volume>63</volume><fpage>9923</fpage><lpage>9932</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2007.04.105</pub-id></citation></ref>
<ref id="b27-marinedrugs-09-02469"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolognesi</surname><given-names>M.L.</given-names></name><name><surname>Ai Tran</surname><given-names>H.N.</given-names></name><name><surname>Staderini</surname><given-names>M.</given-names></name><name><surname>Monaco</surname><given-names>A.</given-names></name><name><surname>López-Cobeñas</surname><given-names>A.</given-names></name><name><surname>Bongarzone</surname><given-names>S.</given-names></name><name><surname>Biarnés</surname><given-names>X.</given-names></name><name><surname>López-Alvarado</surname><given-names>P.</given-names></name><name><surname>Cabezas</surname><given-names>N.</given-names></name><name><surname>Caramelli</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Discovery of a class of diketopiperazines as antiprion compounds</article-title><source>ChemMedChem</source><year>2010</year><volume>5</volume><fpage>1324</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1002/cmdc.201000133</pub-id><pub-id pub-id-type="pmid">20540064</pub-id></citation></ref>
<ref id="b28-marinedrugs-09-02469"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name></person-group><article-title>Diketopiperazines from Marine Organisms</article-title><source>Chem. Biodivs</source><year>2007</year><volume>7</volume><fpage>2809</fpage><lpage>2829</lpage></citation></ref>
<ref id="b29-marinedrugs-09-02469"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ovenden</surname><given-names>S.P.B.</given-names></name><name><surname>Nielson</surname><given-names>J.L.</given-names></name><name><surname>Liptrot</surname><given-names>C.H.</given-names></name><name><surname>Willis</surname><given-names>R.H.</given-names></name><name><surname>Wright</surname><given-names>A.D.</given-names></name><name><surname>Motti</surname><given-names>C.A.</given-names></name><name><surname>Tapiolas</surname><given-names>D.M.</given-names></name><name><surname>Wright</surname><given-names>A.D.</given-names></name></person-group><article-title>Comosusols A–D and Comosone A: Cytotoxic compounds from the brown alga <italic>Sporochnus comosus</italic></article-title><source>J. Nat. Prod</source><year>2011</year><volume>74</volume><fpage>739</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1021/np1008009</pub-id><pub-id pub-id-type="pmid">21348445</pub-id></citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-marinedrugs-09-02469" position="float">
<label>Figure 1</label>
<caption>
<p>Minimum energy conformation of <bold>1</bold> obtained from MM2 calculations without applying any dihedral angle constraints [<xref ref-type="bibr" rid="b23-marinedrugs-09-02469">23</xref>]. The calculated dihedral angles for H<sub>b</sub>-3–C-3– C-4–H-4 (−93°), H-4–C-4–C-4–H<sub>a</sub>-5 (79°) and for 8-N<underline>H</underline>–N-8–C-9–H-9 (91°), all which approximate 90° as observed experimentally from the <sup>1</sup>H–<sup>1</sup>H coupling constants, are indicative of the absolute configurations at C-4 as being <italic>S</italic> and at both C-6 and C-9 being <italic>R</italic>.</p></caption>
<graphic xlink:href="marinedrugs-09-02469f1.gif"/></fig>
<fig id="f2-marinedrugs-09-02469" position="float">
<label>Scheme 1</label>
<caption>
<p>Structures of the bengazoles, bengamides and <bold>1</bold> isolated from <italic>Stelletta</italic> sp. and the proposed enzymatically controlled condensation reaction between D-isoleucine and 4-<italic>S</italic>-hydroxy-<sc>d</sc>-proline to yield <bold>1</bold>.</p></caption>
<graphic xlink:href="marinedrugs-09-02469f2.gif"/></fig>
<table-wrap id="t1-marinedrugs-09-02469" position="float">
<label>Table 1</label>
<caption>
<p>NMR data for <bold>1</bold> (600 MHz, <italic>d</italic><sub>6</sub>-DMSO), cyclo-[<italic>S</italic>-proline-<italic>S</italic>-isoleucine)] (300 MHz, CDCl<sub>3</sub>) and <sup>1</sup>H NMR data for cyclo[<sc>l</sc>-(4-hydroxyprolinyl)-<sc>l</sc>-leucine)] (300 MHz, CD<sub>3</sub>OD).</p></caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="center" valign="middle">No.</th>
<th align="center" valign="middle"><sup>13</sup>C δ (m)</th>
<th align="center" valign="middle"><sup>1</sup>H δ (m, <italic>J</italic> Hz)</th>
<th align="center" valign="middle">COSY</th>
<th align="center" valign="middle">gHMBC</th>
<th align="center" valign="middle"><sup>1</sup>H δ (m, <italic>J</italic> Hz) of cyclo-[<italic>S</italic>-proline-<italic>S</italic>-isoleucine)] [<xref ref-type="bibr" rid="b3-marinedrugs-09-02469">3</xref>]</th>
<th align="center" valign="middle"><sup>1</sup>H δ (m, <italic>J</italic> Hz) of cyclo[<sc>l</sc>-(4-hydroxyprolinyl)-<sc>l</sc>-leucine)] [<xref ref-type="bibr" rid="b6-marinedrugs-09-02469">6</xref>]</th></tr></thead>
<tbody>
<tr>
<td align="center" valign="middle">1</td>
<td align="right" valign="middle">165.4 (s)</td>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/></tr>
<tr>
<td align="center" valign="middle">2</td>
<td align="right" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/></tr>
<tr>
<td align="center" valign="middle">3</td>
<td align="right" valign="middle">53.8 (t)</td>
<td align="left" valign="middle">3.51 (1H, dd, 12.5, 4.6)<break/>3.20 (1H, d, 12.5)</td>
<td align="left" valign="middle">H<sub>b</sub>-3, H-4<break/>H<sub>a</sub>-3</td>
<td align="left" valign="middle">C-1, C-4, C-5, C-6<break/>C-1, C-4, C-5, C-6</td>
<td align="left" valign="middle">3.6–3.5 (2H, m)</td>
<td align="left" valign="middle">3.65 (1H, dd, 12.5, 4.3)<break/>3.42 (1H, d, 12.5)</td></tr>
<tr>
<td align="center" valign="middle">4</td>
<td align="right" valign="middle">66.8 (d)</td>
<td align="left" valign="middle">4.28 (1H, br dd, 4.6, 4.6)</td>
<td align="left" valign="middle">H<sub>a</sub>-3, 4-OH, H<sub>b</sub>-5</td>
<td align="left" valign="middle">C-3, C-6</td>
<td align="left" valign="middle">2.0–1.9 (1H, m)<break/>1.9–1.8 (1H, m)</td>
<td align="left" valign="middle">4.28 (1H, t, 4.3)</td></tr>
<tr>
<td align="center" valign="middle">4-O<underline>H</underline></td>
<td align="right" valign="middle"/>
<td align="left" valign="middle">5.10 (O<underline>H</underline>, br s,)</td>
<td align="left" valign="middle">H-4</td>
<td align="left" valign="middle"/>
<td align="left" valign="middle">-</td>
<td align="left" valign="middle">-</td></tr>
<tr>
<td align="center" valign="middle">5</td>
<td align="right" valign="middle">37.2 (t)</td>
<td align="left" valign="middle">2.03 (1H, dd, 12.9, 6.1)<break/>1.88 (1H, ddd, 12.9, 11.0, 4.6)</td>
<td align="left" valign="middle">H<sub>b</sub>-5, H-6<break/>H-4, H<sub>a</sub>-5, H-6</td>
<td align="left" valign="middle">C-3, C-4<break/>C-4, C-6, C-7</td>
<td align="left" valign="middle">2.3–2.2 (1H, m)<break/>2.1–2.0 (1H, m)</td>
<td align="left" valign="middle">2.27 (1H, dd, 13.3, 6.5)<break/>2.08 (1H, ddd, 13.3, 11.1, 4.3)</td></tr>
<tr>
<td align="center" valign="middle">6</td>
<td align="right" valign="middle">56.7 (d)</td>
<td align="left" valign="middle">4.31 (1H, dd, 11.0, 6.1)</td>
<td align="left" valign="middle">H<sub>2</sub>-5</td>
<td align="left" valign="middle">C-5, C-7</td>
<td align="left" valign="middle">4.07 (1H, t, 7.5)</td>
<td align="left" valign="middle">4.51 (1H, dd, 11.1, 6.5)</td></tr>
<tr>
<td align="center" valign="middle">7</td>
<td align="right" valign="middle">170.5 (s)</td>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/></tr>
<tr>
<td align="center" valign="middle">8-N<underline>H</underline></td>
<td align="right" valign="middle"/>
<td align="left" valign="middle">7.97 (1<underline>H</underline>, s)</td>
<td align="left" valign="middle">H-9</td>
<td align="left" valign="middle">C-1, C-6, C-7, C-9, C-10</td>
<td align="left" valign="middle">5.99 (1H, br s)</td>
<td align="left" valign="middle">exchangeable</td></tr>
<tr>
<td align="center" valign="middle">9</td>
<td align="right" valign="middle">59.1 (d)</td>
<td align="left" valign="middle">4.00 (1H, br s)</td>
<td align="left" valign="middle">8-N<underline>H</underline> (w), H-10</td>
<td align="left" valign="middle">C-1, C-7, C-10, C-11, C-13</td>
<td align="left" valign="middle">3.96 (1H, br s)</td>
<td align="left" valign="middle">4.15 (1H, m)</td></tr>
<tr>
<td align="center" valign="middle">10</td>
<td align="right" valign="middle">34.8 (d)</td>
<td align="left" valign="middle">2.01 (1H, m)</td>
<td align="left" valign="middle">H-9, H<sub>b</sub>-11, H<sub>3</sub>-13</td>
<td align="left" valign="middle">C-1, C-13, C-11</td>
<td align="left" valign="middle">2.4–2.3 (1H, m)</td>
<td align="left" valign="middle">1.90 (1H, m)<break/>1.50 (1H, dd, 8.0)</td></tr>
<tr>
<td align="center" valign="middle">11</td>
<td align="right" valign="middle">23.9 (t)</td>
<td align="left" valign="middle">1.32 (1H, qdd, 11.8, 7.4, 4.5)<break/>1.26 (1H, qdd, 11.8, 9.2, 7.2)</td>
<td align="left" valign="middle">H<sub>b</sub>-11, H<sub>3</sub>-12<break/>H-10, H<sub>a</sub>-11, H<sub>3</sub>-12</td>
<td align="left" valign="middle">C-9, C-10, C-12, C-13<break/>C-9, C-10, C-12, C-13</td>
<td align="left" valign="middle">1.5–1.4 (1H, m)<break/>1.3–1.1 (1H, m)</td>
<td align="left" valign="middle">1.88 (1H, m)</td></tr>
<tr>
<td align="center" valign="middle">12</td>
<td align="right" valign="middle">12.3 (q)</td>
<td align="left" valign="middle">0.82 (3H, t, 7.4)</td>
<td align="left" valign="middle">H<sub>2</sub>-11</td>
<td align="left" valign="middle">C-10, C-11</td>
<td align="left" valign="middle">0.92 (3H, t, 7.4)</td>
<td align="left" valign="middle">0.95 (3H, d, 6.4)</td></tr>
<tr>
<td align="center" valign="middle">13</td>
<td align="right" valign="middle">14.9 (q)</td>
<td align="left" valign="middle">0.97 (3H, d, 7.0)</td>
<td align="left" valign="middle">H-10</td>
<td align="left" valign="middle">C-9, C-10, C-11</td>
<td align="left" valign="middle">1.05 (3H, d, 7.2)</td>
<td align="left" valign="middle">0.96 (3H, d, 6.4)</td></tr></tbody></table></table-wrap>
<table-wrap id="t2-marinedrugs-09-02469" position="float">
<label>Table 2</label>
<caption>
<p>GI<sub>50</sub> (μM) data for compounds <bold>1</bold>–<bold>8</bold> against SF-268, MCF-7, H460, HT-29 and CHO-K1.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="bottom">No.</th>
<th align="center" valign="bottom">SF-268 <xref ref-type="table-fn" rid="tfn1-marinedrugs-09-02469">a</xref></th>
<th align="center" valign="bottom">MCF-7 <xref ref-type="table-fn" rid="tfn2-marinedrugs-09-02469">b</xref></th>
<th align="center" valign="bottom">H460 <xref ref-type="table-fn" rid="tfn3-marinedrugs-09-02469">c</xref></th>
<th align="center" valign="bottom">HT-29 <xref ref-type="table-fn" rid="tfn4-marinedrugs-09-02469">d</xref></th>
<th align="center" valign="bottom">CHO-K1 <xref ref-type="table-fn" rid="tfn5-marinedrugs-09-02469">e</xref></th></tr></thead>
<tbody>
<tr>
<td align="center" valign="top"><bold>1</bold></td>
<td align="center" valign="top">&gt;295</td>
<td align="center" valign="top">204</td>
<td align="center" valign="top">234</td>
<td align="center" valign="top">270</td>
<td align="center" valign="top">&gt;295</td></tr>
<tr>
<td align="center" valign="top"><bold>2</bold></td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">0.1</td></tr>
<tr>
<td align="center" valign="top"><bold>3</bold></td>
<td align="center" valign="top">1.8</td>
<td align="center" valign="top">0.7</td>
<td align="center" valign="top">0.6</td>
<td align="center" valign="top">1.5</td>
<td align="center" valign="top">32</td></tr>
<tr>
<td align="center" valign="top"><bold>4</bold></td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">0.2</td></tr>
<tr>
<td align="center" valign="top"><bold>5</bold></td>
<td align="center" valign="top">72</td>
<td align="center" valign="top">52</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">48</td>
<td align="center" valign="top">&gt;184</td></tr>
<tr>
<td align="center" valign="top"><bold>6</bold></td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">94</td></tr>
<tr>
<td align="center" valign="top"><bold>7</bold></td>
<td align="center" valign="top">0.3</td>
<td align="center" valign="top">0.8</td>
<td align="center" valign="top">0.1</td>
<td align="center" valign="top">0.6</td>
<td align="center" valign="top">1.2</td></tr>
<tr>
<td align="center" valign="top"><bold>8</bold></td>
<td align="center" valign="top">0.02</td>
<td align="center" valign="top">0.06</td>
<td align="center" valign="top">&lt;0.02</td>
<td align="center" valign="top">0.1</td>
<td align="center" valign="top">0.8</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-marinedrugs-09-02469">
<label>a</label>
<p>SF-268 Central nervous system-glioblastoma cells;</p></fn><fn id="tfn2-marinedrugs-09-02469">
<label>b</label>
<p>MCF-7 Breast-pleural effusion adenocarcinoma cells;</p></fn><fn id="tfn3-marinedrugs-09-02469">
<label>c</label>
<p>H460 Lung-large cell carcinoma cells;</p></fn><fn id="tfn4-marinedrugs-09-02469">
<label>d</label>
<p>HT-29 Colon-recto-sigmoid colon adenocarcinoma cells;</p></fn><fn id="tfn5-marinedrugs-09-02469">
<label>e</label>
<p>CHO-K1 Sub-clone of Chinese hamster ovary cells.</p></fn></table-wrap-foot></table-wrap></sec></back></article>
